Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2023 it was C$9.30M, down 36.8% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | C$9.30M | -36.8% |
| FY2022 | Mar 31, 2022 | C$14.72M | +35.4% |
| FY2021 | Mar 31, 2021 | C$10.87M | +85.2% |
| FY2020 | Mar 31, 2020 | C$5.87M | – |
See a number that looks wrong?